Takuya Morikawa

Mie University Hospital

Papers

1

Total Citations

49

H-Index

1

About

Takuya Morikawa is a leading researcher in pharmaceutical robotics and the safe handling of hazardous drugs, with a particular focus on automating the compounding of injectable anticancer agents. His most cited work evaluates the APOTECAchemo compounding robot in a Japanese hospital setting, demonstrating its accuracy, safety, and feasibility for clinical practice. This study, which has garnered 49 citations, systematically assessed robotic preparations of fluorouracil and cyclophosphamide, providing critical evidence for the adoption of automation to reduce human exposure to cytotoxic drugs and improve dosing precision. Morikawa’s contributions are pivotal in bridging the gap between advanced robotic technology and real-world hospital pharmacy operations, addressing both occupational safety and medication error reduction. His research has influenced the integration of robotic systems in Japanese healthcare, setting a benchmark for performance evaluation protocols. By championing evidence-based implementation of compounding robots, Morikawa has established himself as a key figure in the movement toward safer, more efficient chemotherapy preparation, directly impacting patient care and pharmacy practice standards.

Research Focus

Key Achievements

1
H-Index
1
Papers
49
Total Citations
49
Avg Citations/Paper
🏆 Most Cited Paper
Performance evaluation of the compounding robot, APOTECAchemo, for injectable anticancer drugs in a Japanese hospital
49 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Mie University Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago